Class III medical devices in Taiwan are considered high-risk products that require rigorous evaluation and approval before market entry. This category includes devices such as pacemakers, artificial joints, and implantable devices. Manufacturers must provide extensive clinical data and undergo thorough review by the TFDA to ensure safety, efficacy, and compliance with regulatory standards.